Review of nano-based devices planned by EU committee

04/2/2012 | Clinica (subscription required)

The European Commission's Scientific Committee on Emerging and Newly Identified Health Risks has been asked to perform a risk evaluation of medical devices that use nanomaterials and submit feedback by next March. The commission will use the feedback to help craft proposals on labeling, risk categorization and instructions for these devices.

View Full Article in:

Clinica (subscription required)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr Statistician I (US/TB/00/0028/SL)
Abbott
Santa Clara, CA
Food & Drug Associate
Confidential
Washington, D.C., DC
Senior Manager, Gaps in Care
UAW Retiree Medical Benefits Trust
Detroit, MI
Compliance Director
Abbott Laboratories
Santa Clara, CA
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA